B

Bionoid Pharma Inc
OTC:BINP

Watchlist Manager
Bionoid Pharma Inc
OTC:BINP
Watchlist
Price: 0.094 USD -14.31% Market Closed
Market Cap: $5.1m

Bionoid Pharma Inc
Total Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Bionoid Pharma Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
B
Bionoid Pharma Inc
OTC:BINP
Total Current Assets
$20k
CAGR 3-Years
-21%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Total Current Assets
$8.8B
CAGR 3-Years
15%
CAGR 5-Years
6%
CAGR 10-Years
10%
Edwards Lifesciences Corp
NYSE:EW
Total Current Assets
$6.7B
CAGR 3-Years
30%
CAGR 5-Years
17%
CAGR 10-Years
13%
Stryker Corp
NYSE:SYK
Total Current Assets
$14.8B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Total Current Assets
$26B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Current Assets
$9.8B
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
16%
No Stocks Found

Bionoid Pharma Inc
Glance View

Market Cap
5.1m USD
Industry
Health Care

Bionoid Pharma, Inc. operates as a medical device company. The company is headquartered in Huntington Beach, California. The company went IPO on 2007-06-25. The firm develops and markets medical devices and technologies for the orthopedic and pain management markets. The firm develops and commercializes a platform called muscle pattern recognition (MPR), a clinical tool for the analysis of muscle function in patients presenting with back pain. MPR provides information regarding muscle recruitment patterns in patients suffering from neck and back pain that can assist healthcare professionals in the evaluation and treatment of neck and back injuries and illnesses. The Company, through BIOflex Medical Magnetics, Inc., develops and sells magnetic therapy devices. The firm sells its products through several channels, including Web-based sales; corporate partnerships; direct response television (DRTV); retail distribution; Internet catalogs, and through a network of distributors across the world.

BINP Intrinsic Value
Not Available

See Also

What is Bionoid Pharma Inc's Total Current Assets?
Total Current Assets
20k USD

Based on the financial report for Dec 31, 2011, Bionoid Pharma Inc's Total Current Assets amounts to 20k USD.

What is Bionoid Pharma Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
0%

Over the last year, the Total Current Assets growth was -98%. The average annual Total Current Assets growth rates for Bionoid Pharma Inc have been -21% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett